Wellington Management Group LLP decreased its stake in LDR Holding Corp (NASDAQ:LDRH) by 40.2% during the first quarter, according to its most recent disclosure with the SEC. The firm owned 1,308,869 shares of the medical device company’s stock after selling 881,347 shares during the period. Wellington Management Group LLP owned 4.48% of LDR Holding Corp worth $33,363,000 at the end of the most recent reporting period.
A number of other large investors have also bought and sold shares of LDRH. Menta Capital LLC acquired a new stake in LDR Holding Corp during the first quarter valued at about $204,000. UBS Group AG boosted its stake in LDR Holding Corp by 208.0% in the first quarter. UBS Group AG now owns 10,674 shares of the medical device company’s stock valued at $272,000 after buying an additional 7,208 shares during the period. BlackRock Group LTD boosted its stake in LDR Holding Corp by 35.9% in the first quarter. BlackRock Group LTD now owns 12,790 shares of the medical device company’s stock valued at $326,000 after buying an additional 3,382 shares during the period. Napier Park Global Capital US LP acquired a new stake in LDR Holding Corp during the fourth quarter valued at about $1,148,000. Finally, California State Teachers Retirement System boosted its stake in LDR Holding Corp by 1.5% in the fourth quarter. California State Teachers Retirement System now owns 46,914 shares of the medical device company’s stock valued at $1,178,000 after buying an additional 700 shares during the period.
Shares of LDR Holding Corp (NASDAQ:LDRH) remained flat at $36.98 during mid-day trading on Thursday. The firm has a 50-day moving average of $33.38 and a 200-day moving average of $25.47. LDR Holding Corp has a 52-week low of $16.33 and a 52-week high of $47.12.
Several equities research analysts have issued reports on LDRH shares. Gabelli started coverage on LDR Holding Corp in a research note on Friday, April 15th. They set a “buy” rating and a $38.00 target price for the company. Stephens cut LDR Holding Corp from an “overweight” rating to an “equal weight” rating in a research note on Wednesday, June 15th. Barclays PLC cut LDR Holding Corp from an “overweight” rating to an “equal weight” rating and raised their target price for the stock from $27.00 to $37.00 in a research note on Friday, June 10th. Zacks Investment Research raised LDR Holding Corp from a “sell” rating to a “hold” rating in a research note on Wednesday, April 20th. Finally, Cowen and Company cut LDR Holding Corp from an “outperform” rating to a “market perform” rating and lifted their price objective for the company from $33.00 to $37.00 in a research note on Tuesday, June 14th. Ten investment analysts have rated the stock with a hold rating and four have given a buy rating to the company. LDR Holding Corp has a consensus rating of “Hold” and a consensus price target of $37.73.
LDR Holding Corporation is a medical device company. The Company focuses on designing and commercializing surgical technologies for the treatment of patients suffering from spine disorders. The Company’s primary products are based on its VerteBRIDGE fusion and Mobi non-fusion platforms, both of which are designed for applications in the cervical and lumbar spine.
